Avacta Group signs deal to help scientists who are fighting the coronavirus pandemic

By Greg Wright
Published 6th Apr 2021, 07:41 BST
Updated 6th Apr 2021, 07:42 BST
Dr Alastair SmithDr Alastair Smith
Dr Alastair Smith
THE Yorkshire-based Avacta Group has signed a deal which will help scientists who are fighting the spread of the coronavirus pandemic.

Avacta Group has announced that it has entered into a global distribution agreement with ABCAM plc to sell the group's recently developed SARS-CoV-2 research ELISA Affimer reagents.

In a statement, Avacta said: "Avacta has developed Affimer reagents which can be used in a high performance ELISA laboratory test to detect the SARS-CoV-2 spike protein with high sensitivity and excellent specificity for the spike protein of the original strain of the virus and other dominant variants such as B117 (Kent strain) and D614G.

Hide Ad